Sahebkar A - Search Results

1

Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial.

Beyraghi-Tousi M, Sahebkar A, Houra M, Sarvghadi P, Jamialahmadi T, Bagheri R, Tavallaie S, Gumpricht E, Saberi-Karimian M. Beyraghi-Tousi M, et al. Among authors: sahebkar a. Eur J Paediatr Neurol. 2024 May;50:57-63. doi: 10.1016/j.ejpn.2024.04.009. Epub 2024 Apr 22. Eur J Paediatr Neurol. 2024. PMID: 38669738 Clinical Trial.

2

The Effect of N-Acetyl-DL-Leucine on Neurological Symptoms in a Patient with Ataxia-Telangiectasia: a Case Study.

Saberi-Karimian M, Beyraghi-Tousi M, Mirzadeh M, Gumpricht E, Sahebkar A. Saberi-Karimian M, et al. Among authors: sahebkar a. Cerebellum. 2023 Feb;22(1):96-101. doi: 10.1007/s12311-022-01371-x. Epub 2022 Feb 7. Cerebellum. 2023. PMID: 35128617

3

The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency.

Saberi-Karimian M, Houra M, Jamialahmadi T, Sarvghadi P, Nikbaf M, Akhlaghi S, Sahebkar A. Saberi-Karimian M, et al. Among authors: sahebkar a. Cerebellum. 2023 Dec;22(6):1250-1256. doi: 10.1007/s12311-022-01504-2. Epub 2022 Dec 9. Cerebellum. 2023. PMID: 36482027 Free PMC article.

4

Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial.

Panahi Y, Saberi-Karimian M, Valizadeh O, Behnam B, Saadat A, Jamialahmadi T, Majeed M, Sahebkar A. Panahi Y, et al. Among authors: sahebkar a. Adv Exp Med Biol. 2021;1328:1-9. doi: 10.1007/978-3-030-73234-9_1. Adv Exp Med Biol. 2021. PMID: 34981467 Clinical Trial.

5

The Effects of Curcumin on Serum Heat Shock Protein 27 Antibody Titers in Patients with Metabolic Syndrome.

Mohammadi F, Ghazi-Moradi M, Ghayour-Mobarhan M, Esmaeili H, Moohebati M, Saberi-Karimian M, Safarian H, Tavallaie S, Ferns GA, Sahebkar A. Mohammadi F, et al. Among authors: sahebkar a. J Diet Suppl. 2019;16(5):592-601. doi: 10.1080/19390211.2018.1472710. Epub 2018 Jun 29. J Diet Suppl. 2019. PMID: 29958053 Clinical Trial.

6

The effects of curcumin and a modified curcumin formulation on serum Cholesteryl Ester Transfer Protein concentrations in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial.

Javandoost A, Afshari A, Saberi-Karimian M, Sahebkar A, Safarian H, Moammeri M, Fathi Dizaji B, Tavalaei S, A Ferns G, Pasdar A, Parizadeh SMR, Ghayour-Mobarhan M. Javandoost A, et al. Among authors: a ferns g, sahebkar a. Avicenna J Phytomed. 2018 Jul-Aug;8(4):330-337. Avicenna J Phytomed. 2018. PMID: 30377591 Free PMC article.

7

Does curcumin have an effect on sleep duration in metabolic syndrome patients?

Saberi-Karimian M, Ghazizadeh H, Mohammadzadeh E, Ferns GA, Ghayour-Mobarhan M, Sahebkar A. Saberi-Karimian M, et al. Among authors: sahebkar a. Avicenna J Phytomed. 2021 Mar-Apr;11(2):190-198. Avicenna J Phytomed. 2021. PMID: 33907677 Free PMC article.

8

Curcumin: A Review of Its Effects on Epilepsy.

Forouzanfar F, Majeed M, Jamialahmadi T, Sahebkar A. Forouzanfar F, et al. Among authors: sahebkar a. Adv Exp Med Biol. 2021;1291:363-373. doi: 10.1007/978-3-030-56153-6_21. Adv Exp Med Biol. 2021. PMID: 34331701 Review.

9

Association of ANGPTL3 polymorphisms with high-density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease.

Aghasizadeh M, Nosrati M, Saberi-Karimian M, Safarian H, Assadian P, Akbarpour E, Sahebkar A, Avan A, Ferns GA, Kazemi T, Miri-Moghaddam E, Ghayour-Mobarhan M. Aghasizadeh M, et al. Among authors: sahebkar a. J Clin Lab Anal. 2021 Dec;35(12):e23980. doi: 10.1002/jcla.23980. Epub 2021 Oct 24. J Clin Lab Anal. 2021. PMID: 34689370 Free PMC article.

10

A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial.

Hariri M, Gholami A, Mirhafez SR, Bidkhori M, Sahebkar A. Hariri M, et al. Among authors: sahebkar a. Complement Ther Med. 2020 Jun;51:102447. doi: 10.1016/j.ctim.2020.102447. Epub 2020 May 16. Complement Ther Med. 2020. PMID: 32507446 Clinical Trial.

11

Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial.

Rahimnia AR, Panahi Y, Alishiri G, Sharafi M, Sahebkar A. Rahimnia AR, et al. Among authors: sahebkar a. Drug Res (Stuttg). 2015 Oct;65(10):521-5. doi: 10.1055/s-0034-1384536. Epub 2014 Jul 22. Drug Res (Stuttg). 2015. PMID: 25050518 Clinical Trial.

12

Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial.

Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A. Panahi Y, et al. Among authors: sahebkar a. Drug Res (Stuttg). 2015 Nov;65(11):567-73. doi: 10.1055/s-0034-1389986. Epub 2014 Sep 30. Drug Res (Stuttg). 2015. PMID: 25268878 Clinical Trial.

13

Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease.

Mirhafez SR, Rezai A, Dehabeh M, Nobakht M Gh BF, Bidkhori M, Sahebkar A, Hariri M. Mirhafez SR, et al. Among authors: sahebkar a. Int J Vitam Nutr Res. 2021 Jun;91(3-4):278-286. doi: 10.1024/0300-9831/a000629. Epub 2019 Dec 10. Int J Vitam Nutr Res. 2021. PMID: 31818232 Free article. Clinical Trial.

14

A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.

Panahi Y, Moghaddam BR, Sahebkar A, Nazari MA, Beiraghdar F, Karami G, Saadat AR. Panahi Y, et al. Among authors: sahebkar a. Psychol Med. 2011 Oct;41(10):2159-66. doi: 10.1017/S0033291711000201. Epub 2011 Feb 24. Psychol Med. 2011. PMID: 21349225 Clinical Trial.

15

Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial.

Khonche A, Biglarian O, Panahi Y, Valizadegan G, Soflaei SS, Ghamarchehreh ME, Majeed M, Sahebkar A. Khonche A, et al. Among authors: sahebkar a. Drug Res (Stuttg). 2016 Aug;66(8):444-8. doi: 10.1055/s-0042-109394. Epub 2016 Jun 28. Drug Res (Stuttg). 2016. PMID: 27351245 Clinical Trial.

16

Serum osteopontin concentrations in relation to coronary artery disease.

Mohamadpour AH, Abdolrahmani L, Mirzaei H, Sahebkar A, Moohebati M, Ghorbani M, Ferns GA, Ghayour-Mobarhan M. Mohamadpour AH, et al. Among authors: sahebkar a. Arch Med Res. 2015 Feb;46(2):112-7. doi: 10.1016/j.arcmed.2015.02.005. Epub 2015 Mar 2. Arch Med Res. 2015. PMID: 25743929

17

Comparative trial of Aloe vera/olive oil combination cream versus phenytoin cream in the treatment of chronic wounds.

Panahi Y, Izadi M, Sayyadi N, Rezaee R, Jonaidi-Jafari N, Beiraghdar F, Zamani A, Sahebkar A. Panahi Y, et al. Among authors: sahebkar a. J Wound Care. 2015 Oct;24(10):459-60, 462-5. doi: 10.12968/jowc.2015.24.10.459. J Wound Care. 2015. PMID: 26488737 Clinical Trial.

18

Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation.

Matbou Riahi M, Sahebkar A, Sadri K, Nikoofal-Sahlabadi S, Jaafari MR. Matbou Riahi M, et al. Among authors: sahebkar a. Int J Pharm. 2018 Apr 5;540(1-2):89-97. doi: 10.1016/j.ijpharm.2018.01.039. Epub 2018 Jan 31. Int J Pharm. 2018. PMID: 29371019

19

SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS.

Panahi Y, Bonakdaran S, Yaghoubi MA, Keramati MR, Haratian M, Sahebkar A. Panahi Y, et al. Among authors: sahebkar a. Acta Endocrinol (Buchar). 2016 Jul-Sep;12(3):257-261. doi: 10.4183/aeb.2016.257. Acta Endocrinol (Buchar). 2016. PMID: 31149098 Free PMC article.

20

Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue.

Ramezani M, Hatamipour M, Sahebkar A. Ramezani M, et al. Among authors: sahebkar a. J Cell Physiol. 2018 Feb;233(2):880-887. doi: 10.1002/jcp.25795. Epub 2017 May 16. J Cell Physiol. 2018. PMID: 28075008 Review.

21

Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer.

Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, Ariakia F, Fiuji H, Sahebkar A, Avan A, Khazaei M. Marjaneh RM, et al. Among authors: sahebkar a. J Cell Physiol. 2018 Oct;233(10):6785-6798. doi: 10.1002/jcp.26538. Epub 2018 May 8. J Cell Physiol. 2018. Retraction in: J Cell Physiol. 2025 Apr;240(4):e70018. doi: 10.1002/jcp.70018. PMID: 29737515 Retracted.

22

The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials.

Ansari L, Shiehzadeh F, Taherzadeh Z, Nikoofal-Sahlabadi S, Momtazi-Borojeni AA, Sahebkar A, Eslami S. Ansari L, et al. Among authors: sahebkar a. Cancer Gene Ther. 2017 May;24(5):189-193. doi: 10.1038/cgt.2017.9. Epub 2017 Apr 14. Cancer Gene Ther. 2017. PMID: 28409561 Review.

23

Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species.

Karamoddini MK, Fazli-Bazzaz BS, Emamipour F, Ghannad MS, Jahanshahi AR, Saed N, Sahebkar A. Karamoddini MK, et al. Among authors: sahebkar a. ScientificWorldJournal. 2011 Jul 7;11:1332-40. doi: 10.1100/tsw.2011.114. ScientificWorldJournal. 2011. PMID: 21789469 Free PMC article.

24

High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.

Samadi S, Mehramiz M, Kelesidis T, Mobarhan MG, Sahebkar AH, Esmaily H, Moohebati M, Farjami Z, Ferns GA, Mohammadpour AH, Avan A. Samadi S, et al. Among authors: sahebkar ah. J Cell Physiol. 2019 Sep;234(9):16168-16177. doi: 10.1002/jcp.28276. Epub 2019 Feb 19. J Cell Physiol. 2019. PMID: 30784041 Free PMC article.

25

PiggyBac as a novel vector in cancer gene therapy: current perspective.

Mirzaei H, Sahebkar A, Jaafari MR, Hadjati J, Javanmard SH, Mirzaei HR, Salehi R. Mirzaei H, et al. Among authors: sahebkar a. Cancer Gene Ther. 2016 Feb-Mar;23(2-3):45-7. doi: 10.1038/cgt.2015.68. Epub 2016 Jan 8. Cancer Gene Ther. 2016. PMID: 26742580

26

Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.

Fathullahzadeh S, Mirzaei H, Honardoost MA, Sahebkar A, Salehi M. Fathullahzadeh S, et al. Among authors: sahebkar a. Cancer Gene Ther. 2016 Oct;23(10):327-332. doi: 10.1038/cgt.2016.34. Epub 2016 Sep 23. Cancer Gene Ther. 2016. PMID: 27659777

27

Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo.

Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H. Iranshahi M, et al. Among authors: sahebkar a. Phytomedicine. 2010 Mar;17(3-4):269-73. doi: 10.1016/j.phymed.2009.05.020. Epub 2009 Jul 3. Phytomedicine. 2010. PMID: 19577457

28

Research in the Middle East into the Health Benefits of Curcumin.

Guest PC, Sahebkar A. Guest PC, et al. Among authors: sahebkar a. Adv Exp Med Biol. 2021;1291:1-13. doi: 10.1007/978-3-030-56153-6_1. Adv Exp Med Biol. 2021. PMID: 34331681 Review.

29

Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties.

Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A. Hatamipour M, et al. Among authors: sahebkar a. J Cell Physiol. 2018 Dec;233(12):9247-9260. doi: 10.1002/jcp.27029. Epub 2018 Aug 4. J Cell Physiol. 2018. PMID: 30076727 Review.

30

Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review.

Naderi Y, Panahi Y, Barreto GE, Sahebkar A. Naderi Y, et al. Among authors: sahebkar a. Neural Regen Res. 2020 May;15(5):773-782. doi: 10.4103/1673-5374.268898. Neural Regen Res. 2020. PMID: 31719236 Free PMC article. Review.

31

Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features.

Teymouri M, Pirro M, Johnston TP, Sahebkar A. Teymouri M, et al. Among authors: sahebkar a. Biofactors. 2017 May 6;43(3):331-346. doi: 10.1002/biof.1344. Epub 2016 Nov 29. Biofactors. 2017. PMID: 27896883 Review.

32

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.

Fairoozy RH, Futema M, Vakili R, Abbaszadegan MR, Hosseini S, Aminzadeh M, Zaeri H, Mobini M, Humphries SE, Sahebkar A. Fairoozy RH, et al. Among authors: sahebkar a. Sci Rep. 2017 Dec 6;7(1):17087. doi: 10.1038/s41598-017-17181-9. Sci Rep. 2017. PMID: 29213121 Free PMC article.

33

IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases.

Teymouri M, Pirro M, Fallarino F, Gargaro M, Sahebkar A. Teymouri M, et al. Among authors: sahebkar a. Int J Cancer. 2018 Nov 1;143(9):2105-2115. doi: 10.1002/ijc.31382. Epub 2018 Mar 31. Int J Cancer. 2018. PMID: 29574719 Review.

34

The role of microRNAs in embryonic stem cell and induced pluripotent stem cell differentiation in male germ cells.

Mahabadi JA, Sabzalipoor H, Nikzad H, Seyedhosseini E, Enderami SE, Gheibi Hayat SM, Sahebkar A. Mahabadi JA, et al. Among authors: sahebkar a. J Cell Physiol. 2019 Aug;234(8):12278-12289. doi: 10.1002/jcp.27990. Epub 2018 Dec 10. J Cell Physiol. 2019. PMID: 30536380 Review.

35

Shedding light on the EpCAM: An overview.

Yahyazadeh Mashhadi SM, Kazemimanesh M, Arashkia A, Azadmanesh K, Meshkat Z, Golichenari B, Sahebkar A. Yahyazadeh Mashhadi SM, et al. Among authors: sahebkar a. J Cell Physiol. 2019 Aug;234(8):12569-12580. doi: 10.1002/jcp.28132. Epub 2019 Jan 9. J Cell Physiol. 2019. PMID: 30628064 Review.

36

Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.

Teymouri M, Barati N, Pirro M, Sahebkar A. Teymouri M, et al. Among authors: sahebkar a. J Cell Physiol. 2018 Jan;233(1):124-140. doi: 10.1002/jcp.25749. Epub 2017 Mar 31. J Cell Physiol. 2018. PMID: 27996095 Review.

37

Enhancing TB diagnosis: Improving specificity with scFv antibodies targeting the PPE17 epitope.

Heidarnejad K, Bahtouee M, Faraji SN, Moazen S, Abbasi F, Sahebkar A, Nejatollahi F. Heidarnejad K, et al. Among authors: sahebkar a. Tissue Cell. 2025 Apr 29;96:102933. doi: 10.1016/j.tice.2025.102933. Online ahead of print. Tissue Cell. 2025. PMID: 40349557

38

Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation.

Arghidash F, Gheybi F, Gholamhosseinian H, Kesharwani P, Sahebkar A. Arghidash F, et al. Among authors: sahebkar a. Pathol Res Pract. 2025 May 7;270:156002. doi: 10.1016/j.prp.2025.156002. Online ahead of print. Pathol Res Pract. 2025. PMID: 40347920 Review.

39

Angiopoietin-like protein inhibitors: Promising agents for the treatment of familial hypercholesterolemia and atherogenic dyslipidemia.

Vahdat-Lasemi F, Farhoudi L, Hosseinikhah SM, Santos RD, Sahebkar A. Vahdat-Lasemi F, et al. Among authors: sahebkar a. Atherosclerosis. 2025 May 2;405:119235. doi: 10.1016/j.atherosclerosis.2025.119235. Online ahead of print. Atherosclerosis. 2025. PMID: 40344904 Review.

40

Recent advances in PD-L1 siRNA nanocarriers for cancer therapy.

Sristi, Gupta G, Abourehab MAS, Sahebkar A, Kesharwani P. Sristi, et al. Among authors: sahebkar a. Int J Biol Macromol. 2025 May 6;311(Pt 3):143994. doi: 10.1016/j.ijbiomac.2025.143994. Online ahead of print. Int J Biol Macromol. 2025. PMID: 40339860 Review.

41

Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.

GBD 2019 Acute and Chronic Care Collaborators. GBD 2019 Acute and Chronic Care Collaborators. Nat Commun. 2025 May 7;16(1):4235. doi: 10.1038/s41467-025-56910-x. Nat Commun. 2025. PMID: 40335470 Free PMC article.

42

The impact of nut consumption on vascular endothelial function: a GRADE-assessed systematic review and meta-analysis of data from randomised controlled trials.

Arabi SM, Rahnama I, Malek-Ahmadi M, Chambari M, Bahrami LS, Milkarizi N, Hatami A, Sukhorukov VN, Sahebkar A. Arabi SM, et al. Among authors: sahebkar a. Int J Food Sci Nutr. 2025 May 6:1-13. doi: 10.1080/09637486.2025.2499045. Online ahead of print. Int J Food Sci Nutr. 2025. PMID: 40329520

43

G protein-coupled estrogen receptor reduces the breast cancer cell survival by regulating the IRE1α/miR-17-5p/TXNIP pathway.

Mohammad-Sadeghipour M, Nematollahi MH, Sahebazzamani M, Ahmadinia H, Hajizadeh MR, Mahmoodi M, Sahebkar A. Mohammad-Sadeghipour M, et al. Among authors: sahebkar a. J Steroid Biochem Mol Biol. 2025 May 4;252:106770. doi: 10.1016/j.jsbmb.2025.106770. Online ahead of print. J Steroid Biochem Mol Biol. 2025. PMID: 40328365

44

Long-term changes in lipid indices following Roux-en-Y gastric bypass: a meta-analysis.

Jamialahamdi T, Mirhadi E, Abdalla MA, Gadde KM, Almahmeed W, Eid AH, Ahmad S, Ahmad I, Kroh M, Sahebkar A. Jamialahamdi T, et al. Among authors: sahebkar a. Surg Endosc. 2025 May 5. doi: 10.1007/s00464-025-11745-x. Online ahead of print. Surg Endosc. 2025. PMID: 40325244 Review.

45

Liver Transplantation for Non-hepatocellular Carcinoma: The Role of Immune Checkpoint Inhibitors.

Bahrami P, Al Zein M, Eid AH, Sahebkar A. Bahrami P, et al. Among authors: sahebkar a. J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102558. doi: 10.1016/j.jceh.2025.102558. Epub 2025 Mar 27. J Clin Exp Hepatol. 2025. PMID: 40303874 Review.

46

Revolutionizing hypertension treatment: aprocitentan's dual action against resistant hypertension.

Sahebkar A, Eid AH. Sahebkar A, et al. Expert Rev Hematol. 2025 May 2:1-4. doi: 10.1080/17474086.2025.2500607. Online ahead of print. Expert Rev Hematol. 2025. PMID: 40298899 No abstract available.

47

Advances in Apolipoprotein-A4 Biosensing Assays for Depression Diagnosis.

Bahaabadi ZJ, Karav S, Sahebkar A. Bahaabadi ZJ, et al. Among authors: sahebkar a. Crit Rev Anal Chem. 2025 Apr 29:1-12. doi: 10.1080/10408347.2025.2496503. Online ahead of print. Crit Rev Anal Chem. 2025. PMID: 40298379 Review.

48

Application of Platelet-Rich Plasma-Based Scaffolds in Soft and Hard Tissue Regeneration.

Khandan-Nasab N, Torkamanzadeh B, Abbasi B, Mohajeri T, Oskuee RK, Sahebkar A. Khandan-Nasab N, et al. Among authors: sahebkar a. Tissue Eng Part B Rev. 2025 Apr 29. doi: 10.1089/ten.teb.2024.0285. Online ahead of print. Tissue Eng Part B Rev. 2025. PMID: 40296834 Review.

49

Exploring the potential of nanoemulgels for dermatological disorders.

Abbasi U, Khan MZ, Fatima M, Gupta G, Molugulu N, Sahebkar A, Abourehab MAS, Kesharwani P. Abbasi U, et al. Among authors: sahebkar a. J Drug Target. 2025 May 6:1-23. doi: 10.1080/1061186X.2025.2497368. Online ahead of print. J Drug Target. 2025. PMID: 40275860 Review.

50

Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study.

Lee S, Son Y, Hwang J, Kim MS; GBD 2021 Dietary Iron Deficiency Collaborators; Il Shin J, Yon DK, Kassebaum NJ. Lee S, et al. Nat Med. 2025 Apr 22. doi: 10.1038/s41591-025-03624-8. Online ahead of print. Nat Med. 2025. PMID: 40263631

51

Evaluation of the effect of Foeniculum vulgare fruit and Echium amoenum flower combination on the severity of physical and psychological symptoms of premenstrual syndrome.

Motevalli Haghi SS, Sahebkar A, Jamali J, Salari R, Motavasselian M. Motevalli Haghi SS, et al. Among authors: sahebkar a. Avicenna J Phytomed. 2024 Sep-Oct;14(5):570-584. doi: 10.22038/AJP.2024.24208. Avicenna J Phytomed. 2024. PMID: 40255949 Free PMC article.

52

The effects of selected phytochemicals on schizophrenia symptoms: A review.

Zamanian M, Gumpricht E, Salehabadi S, Kesharwani P, Sahebkar A. Zamanian M, et al. Among authors: sahebkar a. Tissue Cell. 2025 Apr 17;95:102911. doi: 10.1016/j.tice.2025.102911. Online ahead of print. Tissue Cell. 2025. PMID: 40253798 Review.

53

The role of CRISPR-Cas9 and CRISPR interference technologies in the treatment of autoimmune diseases.

Khademi Z, Mottaghi-Dastjerdi N, Morad H, Sahebkar A. Khademi Z, et al. Among authors: sahebkar a. Autoimmun Rev. 2025 Apr 10;24(7):103816. doi: 10.1016/j.autrev.2025.103816. Online ahead of print. Autoimmun Rev. 2025. PMID: 40221070 Review.

54

Decoy oligodeoxynucleotides targeting STATs in non-cancer gene therapy.

Mahjoubin-Tehran M, Rezaei S, Kesharwani P, Karav S, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: sahebkar a. Gene. 2025 Jul 15;957:149482. doi: 10.1016/j.gene.2025.149482. Epub 2025 Apr 9. Gene. 2025. PMID: 40216342 Review.

55

Protective effect of Leuco-methylene blue against acetaminophen-induced liver injury: an experimental study.

Efati M, Sahebkar A, Tavallaei S, Alidadi S, Hosseini H, Hamidi-Alamdari D. Efati M, et al. Among authors: sahebkar a. Drug Chem Toxicol. 2025 Apr 10:1-13. doi: 10.1080/01480545.2025.2485347. Online ahead of print. Drug Chem Toxicol. 2025. PMID: 40207489

56

Cell and gene therapeutic approaches in non-alcoholic fatty liver disease.

Poudineh M, Mohammadyari F, Parsamanesh N, Jamialahmadi T, Kesharwani P, Sahebkar A. Poudineh M, et al. Among authors: sahebkar a. Gene. 2025 Jul 10;956:149466. doi: 10.1016/j.gene.2025.149466. Epub 2025 Apr 4. Gene. 2025. PMID: 40189164 Review.

57

Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment.

Radbakhsh S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, Mahmoudi A, Manteghi AA, Bazyari MJ, Cione E, Ferretti G, Sahebkar A. Radbakhsh S, et al. Among authors: sahebkar a. Brain Res. 2025 Jun 15;1857:149607. doi: 10.1016/j.brainres.2025.149607. Epub 2025 Apr 3. Brain Res. 2025. PMID: 40187517 Clinical Trial.

58

The heart of the matter: How gut microbiota-targeted interventions influence cardiovascular diseases.

Abavisani M, Tafti P, Khoshroo N, Ebadpour N, Khoshrou A, Kesharwani P, Sahebkar A. Abavisani M, et al. Among authors: sahebkar a. Pathol Res Pract. 2025 May;269:155931. doi: 10.1016/j.prp.2025.155931. Epub 2025 Mar 29. Pathol Res Pract. 2025. PMID: 40174272 Review.

59

Bavachinin attenuates cerebral ischemia/reperfusion injury in rats via its anti-inflammatory and antioxidant effects.

Atlasbaf A, Kodehei AH, Bahadoran E, Zare I, Yousefzadeh S, Kesharwani P, Naderi Y, Sahebkar A. Atlasbaf A, et al. Among authors: sahebkar a. Tissue Cell. 2025 Mar 28;95:102886. doi: 10.1016/j.tice.2025.102886. Online ahead of print. Tissue Cell. 2025. PMID: 40164017

60

Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.

GBD 2021 Asthma and Allergic Diseases Collaborators. GBD 2021 Asthma and Allergic Diseases Collaborators. Lancet Respir Med. 2025 May;13(5):425-446. doi: 10.1016/S2213-2600(25)00003-7. Epub 2025 Mar 24. Lancet Respir Med. 2025. PMID: 40147466

61

Identification of potential therapeutic targets for stroke using data mining, network analysis, enrichment, and docking analysis.

Hatamipour M, Saremi H, Kesharwani P, Sahebkar A. Hatamipour M, et al. Among authors: sahebkar a. Comput Biol Chem. 2025 Aug;117:108431. doi: 10.1016/j.compbiolchem.2025.108431. Epub 2025 Mar 20. Comput Biol Chem. 2025. PMID: 40127530

62

Hydrogel-based dressing for wound healing: A systematic review of clinical trials.

Hosseini SA, Noruzi S, Kesharwani P, Sahebkar A. Hosseini SA, et al. Among authors: sahebkar a. Int J Biol Macromol. 2025 May;308(Pt 1):142322. doi: 10.1016/j.ijbiomac.2025.142322. Epub 2025 Mar 19. Int J Biol Macromol. 2025. PMID: 40118421 Review.

63

Global, regional, and national burden of household air pollution, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 HAP Collaborators. GBD 2021 HAP Collaborators. Lancet. 2025 Apr 5;405(10485):1167-1181. doi: 10.1016/S0140-6736(24)02840-X. Epub 2025 Mar 18. Lancet. 2025. PMID: 40118081 Free PMC article.

64

The Effects of Curcuminoids Supplementation on Serum Adipokines: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.

Bahrami LS, Rahnama I, Chambari M, Norouzy A, Karav S, Arabi SM, Sahebkar A. Bahrami LS, et al. Among authors: sahebkar a. Phytother Res. 2025 Mar 20. doi: 10.1002/ptr.8471. Online ahead of print. Phytother Res. 2025. PMID: 40109154 Review.

65

Understanding gold nanoparticles and their attributes in ovarian cancer therapy.

Aggarwal R, Sheikh A, Akhtar M, Ghazwani M, Hani U, Sahebkar A, Kesharwani P. Aggarwal R, et al. Among authors: sahebkar a. Mol Cancer. 2025 Mar 20;24(1):88. doi: 10.1186/s12943-025-02280-3. Mol Cancer. 2025. PMID: 40108575 Free PMC article. Review.

66

Investigation of the effects of peanut ball during labor: An updated systematic review and meta-analysis.

Makvandi S, Karimi L, Larki M, Sahebkar A. Makvandi S, et al. Among authors: sahebkar a. Eur J Midwifery. 2025 Mar 14;9. doi: 10.18332/ejm/201345. eCollection 2025. Eur J Midwifery. 2025. PMID: 40093334 Free PMC article.

67

Formulation and development of ACUPA-targeting PEGylated nanoliposomes for treatment of prostate cancer.

Moosavian SA, Amin MR, Alavizadeh SH, Jaafari MR, Kesharwani P, Sahebkar A. Moosavian SA, et al. Among authors: sahebkar a. Tissue Cell. 2025 Mar 4;95:102830. doi: 10.1016/j.tice.2025.102830. Online ahead of print. Tissue Cell. 2025. PMID: 40068280

68

The effect of vitamin E supplementation on serum low-density lipoprotein oxidization: A systematic review and meta-analysis of clinical trials.

Amini S, Navab F, Rouhani MH, Jamialahmadi T, Bagherniya M, Kesharwani P, Sahebkar A. Amini S, et al. Among authors: sahebkar a. Eur J Pharmacol. 2025 Jun 15;997:177491. doi: 10.1016/j.ejphar.2025.177491. Epub 2025 Mar 7. Eur J Pharmacol. 2025. PMID: 40057158 Review.

69

Corrigendum to "Toward a paradigm shift: Oral agents and injectable drugs in the future of obesity management" [Pharmacological Reviews 77 (2025) 100008].

Sahebkar A, Eid AH. Sahebkar A, et al. Pharmacol Rev. 2025 Mar 7;77(3):100047. doi: 10.1016/j.pharmr.2025.100047. Online ahead of print. Pharmacol Rev. 2025. PMID: 40056792 No abstract available.

70

The effect of fermented dairy intake and abdominal obesity in adults: a systematic review and dose-response meta-analysis of cohort studies.

Hashemi Javaheri FS, Nasiri Jounaghani M, Sahebkar A, Norouzzadeh M, Delgarm P, Shahinfar H, Mirdar Harijani A. Hashemi Javaheri FS, et al. Among authors: sahebkar a. Eat Weight Disord. 2025 Mar 7;30(1):23. doi: 10.1007/s40519-025-01733-4. Eat Weight Disord. 2025. PMID: 40055253 Free PMC article. Review.

71

Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.

GBD 2021 Adult BMI Collaborators. GBD 2021 Adult BMI Collaborators. Lancet. 2025 Mar 8;405(10481):813-838. doi: 10.1016/S0140-6736(25)00355-1. Epub 2025 Mar 3. Lancet. 2025. PMID: 40049186 Free PMC article.

72

Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.

GBD 2021 Adolescent BMI Collaborators. GBD 2021 Adolescent BMI Collaborators. Lancet. 2025 Mar 8;405(10481):785-812. doi: 10.1016/S0140-6736(25)00397-6. Epub 2025 Mar 3. Lancet. 2025. PMID: 40049185 Free PMC article.

73

Decoy oligonucleotides targeting NF-κB: a promising therapeutic approach for inflammatory diseases.

Mahjoubin-Tehran M, Rezaei S, Butler AE, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: sahebkar a. Inflamm Res. 2025 Mar 6;74(1):47. doi: 10.1007/s00011-025-02021-8. Inflamm Res. 2025. PMID: 40047902 Review.

74

Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications.

Askarizadeh F, Butler AE, Kesharwani P, Sahebkar A. Askarizadeh F, et al. Among authors: sahebkar a. Food Chem Toxicol. 2025 Jun;200:115369. doi: 10.1016/j.fct.2025.115369. Epub 2025 Mar 3. Food Chem Toxicol. 2025. PMID: 40043936 Review.

75

NLRP3 inflammasomes pathway: a key target for Metformin.

Hosseini Y, Niknejad A, Sabbagh Kashani A, Gholami M, Roustaie M, Mohammadi M, Momtaz S, Atkin SL, Jamialahmadi T, Abdolghaffari AH, Sahebkar A. Hosseini Y, et al. Among authors: sahebkar a. Inflammopharmacology. 2025 Apr;33(4):1729-1760. doi: 10.1007/s10787-025-01702-4. Epub 2025 Mar 5. Inflammopharmacology. 2025. PMID: 40042723 Review.

76

Ammonia-Induced Cell Death: A Novel Frontier to Enhance Cancer Immunotherapy.

Rehman U, Gupta G, Sahebkar A, Kesharwani P. Rehman U, et al. Among authors: sahebkar a. Immunology. 2025 May;175(1):16-20. doi: 10.1111/imm.13918. Epub 2025 Mar 4. Immunology. 2025. PMID: 40035403 Review.

77

Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Oral Disorders Collaborators. GBD 2021 Oral Disorders Collaborators. Lancet. 2025 Mar 15;405(10482):897-910. doi: 10.1016/S0140-6736(24)02811-3. Epub 2025 Feb 27. Lancet. 2025. PMID: 40024264 Free article.

78

Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD Epilepsy Collaborators. GBD Epilepsy Collaborators. Lancet Public Health. 2025 Mar;10(3):e203-e227. doi: 10.1016/S2468-2667(24)00302-5. Epub 2025 Feb 24. Lancet Public Health. 2025. PMID: 40015291 Free PMC article.

79

The potential of curcumin in mitigating acetaminophen-induced liver damage.

Einafshar E, Bahrami P, Pashaei F, Naseri P, Ay Gharanjik A, Mirteimoori A, Daraeebaf N, Marami Y, Sahebkar A, Hosseini H. Einafshar E, et al. Among authors: sahebkar a. Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 26. doi: 10.1007/s00210-025-03907-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40009170 Review.

80

Beneficial effects of okra (Abelmoschus esculentus L.) consumption on anthropometric measures, blood pressure, glycaemic control, lipid profile and liver function tests in randomised controlled trials: a GRADE-assessed systematic review and dose-response meta-analysis.

Jafari A, Mardani H, Parsi Nezhad B, Alaghi A, Sahebkar A. Jafari A, et al. Among authors: sahebkar a. Br J Nutr. 2025 Mar 14;133(5):637-664. doi: 10.1017/S0007114525000303. Epub 2025 Feb 26. Br J Nutr. 2025. PMID: 40007206 Review.

81

Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases.

Nejabat M, Hadizadeh F, Almahmeed W, Sahebkar A. Nejabat M, et al. Among authors: sahebkar a. Drug Discov Today. 2025 Mar;30(3):104316. doi: 10.1016/j.drudis.2025.104316. Epub 2025 Feb 20. Drug Discov Today. 2025. PMID: 39986645 Review.

82

The use of aptamers as therapeutic inhibitors and biosensors of TNF-alpha.

Abianeh HS, Kesharwani P, Sahebkar A. Abianeh HS, et al. Among authors: sahebkar a. Int J Biol Macromol. 2025 May;306(Pt 1):141202. doi: 10.1016/j.ijbiomac.2025.141202. Epub 2025 Feb 17. Int J Biol Macromol. 2025. PMID: 39971069 Review.

83

A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules.

Afshari AR, Sanati M, Aminyavari S, Keshavarzi Z, Ahmadi SS, Oroojalian F, Karav S, Sahebkar A. Afshari AR, et al. Among authors: sahebkar a. Inflammopharmacology. 2025 Mar;33(3):1237-1254. doi: 10.1007/s10787-025-01666-5. Epub 2025 Feb 16. Inflammopharmacology. 2025. PMID: 39955698 Review.

84

Targeting mTOR with curcumin: therapeutic implications for complex diseases.

Khayatan D, Razavi SM, Arab ZN, Nasoori H, Fouladi A, Pasha AVK, Butler AE, Karav S, Momtaz S, Abdolghaffari AH, Sahebkar A. Khayatan D, et al. Among authors: sahebkar a. Inflammopharmacology. 2025 Apr;33(4):1583-1616. doi: 10.1007/s10787-025-01643-y. Epub 2025 Feb 16. Inflammopharmacology. 2025. PMID: 39955697 Review.

85

Drugs from the ocean floor.

Khachab M, Sahebkar A, Eid AH. Khachab M, et al. Among authors: sahebkar a. Pharmacol Rev. 2025 Jan;77(1):100009. doi: 10.1016/j.pharmr.2024.100009. Epub 2024 Dec 27. Pharmacol Rev. 2025. PMID: 39952685 No abstract available.

86

Toward a paradigm shift: Oral agents and injectable drugs in the future of obesity management.

Sahebkar A, Eid AH. Sahebkar A, et al. Pharmacol Rev. 2025 Jan;77(1):100008. doi: 10.1016/j.pharmr.2024.100008. Epub 2024 Dec 27. Pharmacol Rev. 2025. PMID: 39952683 No abstract available.

87

Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis.

Bytyçi I, Bytyqi S, Lewek J, Surma S, Bajraktari G, Henein M, Sahebkar A, Al-Khnifsawi M, Gouni-Berthold I, Pećin I, Toth PP, Paneni F, Katsiki N, Escobar C, Lavie CJ, Gaita D, Santos RD, Cicero AFG, Bielecka-Dabrowa A, Ahmed A, Banach M. Bytyçi I, et al. Among authors: sahebkar a. Eur Heart J Open. 2025 Jan 13;5(1):oeaf001. doi: 10.1093/ehjopen/oeaf001. eCollection 2025 Jan. Eur Heart J Open. 2025. PMID: 39944782 Free PMC article.

88

Baicalin and baicalein against myocardial ischemia-reperfusion injury: A review of the current documents.

Nasiri R, Arefnezhad R, Baniasad K, Hosseini SA, Jeshari AS, Miri M, Lotfi A, Ghaemi MS, Amini-Salehi E, Fatemian H, Rezaei-Tazangi F, Kesharwani P, Tavakoli MR, Sahebkar A. Nasiri R, et al. Among authors: sahebkar a. Tissue Cell. 2025 Apr;93:102772. doi: 10.1016/j.tice.2025.102772. Epub 2025 Feb 5. Tissue Cell. 2025. PMID: 39923649 Review.

89

Predictive performance of noninvasive factors for liver fibrosis in severe obesity: a screening based on machine learning models.

Jamialahmadi T, Looha MA, Jangjoo S, Emami N, Abdalla MA, Ganjali M, Salehabadi S, Karav S, Sathyapalan T, Eid AH, Jangjoo A, Sahebkar A. Jamialahmadi T, et al. Among authors: sahebkar a. J Diabetes Metab Disord. 2025 Jan 18;24(1):54. doi: 10.1007/s40200-025-01564-1. eCollection 2025 Jun. J Diabetes Metab Disord. 2025. PMID: 39834350

90

Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases.

Abolfazli S, Karav S, Johnston TP, Sahebkar A. Abolfazli S, et al. Among authors: sahebkar a. Pharmacol Rep. 2025 Apr;77(2):355-374. doi: 10.1007/s43440-025-00694-w. Epub 2025 Jan 20. Pharmacol Rep. 2025. PMID: 39832074 Review.

91

The long-term and post-prandial effects of berry consumption on endothelial dysfunction in adults: a systematic review and meta-analysis of randomised controlled trials.

Talebi S, Shirani M, Shokri-Mashhadi N, Sadeghi O, Karav S, Bagherniya M, Sahebkar A. Talebi S, et al. Among authors: sahebkar a. Int J Food Sci Nutr. 2025 Mar;76(2):134-164. doi: 10.1080/09637486.2025.2450666. Epub 2025 Jan 19. Int J Food Sci Nutr. 2025. PMID: 39828522 Review.

92

TLR/NLRP3 inflammasome signaling pathways as a main target in frailty, cachexia and sarcopenia.

Shahbaz SK, Mokhlesi A, Sadegh RK, Rahimi K, Jamialahmadi T, Butler AE, Kesharwani P, Sahebkar A. Shahbaz SK, et al. Among authors: sahebkar a. Tissue Cell. 2025 Apr;93:102723. doi: 10.1016/j.tice.2025.102723. Epub 2025 Jan 9. Tissue Cell. 2025. PMID: 39823704 Review.

93

Effect of Fibrates on Lipoprotein-associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Controlled Clinical Trials.

Simental-Mendia LE, Simental-Mendía M, Gamboa-Gomez CI, Jamialahmadi T, Sahebkar A. Simental-Mendia LE, et al. Among authors: sahebkar a. Curr Pharm Des. 2025;31(15):1205-1212. doi: 10.2174/0113816128345231240925095400. Curr Pharm Des. 2025. PMID: 39812055 Review.

94

Recent advances in lipid-based nanocarriers for advanced skin cancer therapy.

Ali MS, Abdullah Almoyad MA, Wahab S, Sahebkar A, Gorain B, Kaur H, Kesharwani P. Ali MS, et al. Among authors: sahebkar a. Int J Pharm. 2025 Feb 10;670:125203. doi: 10.1016/j.ijpharm.2025.125203. Epub 2025 Jan 9. Int J Pharm. 2025. PMID: 39798625 Review.

95

Dr. Muhammed Majeed: Father of Indian nutraceuticals industry- a life profile.

Majeed A, Majeed S, Sahebkar A. Majeed A, et al. Among authors: sahebkar a. J Ayurveda Integr Med. 2025 Jan-Feb;16(1):101074. doi: 10.1016/j.jaim.2024.101074. Epub 2025 Jan 10. J Ayurveda Integr Med. 2025. PMID: 39793484 Free PMC article. No abstract available.

96

Beyond the Hayflick limit: How microbes influence cellular aging.

Abavisani M, Faraji S, Ebadpour N, Karav S, Sahebkar A. Abavisani M, et al. Among authors: sahebkar a. Ageing Res Rev. 2025 Feb;104:102657. doi: 10.1016/j.arr.2025.102657. Epub 2025 Jan 7. Ageing Res Rev. 2025. PMID: 39788433 Review.

97

Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in an experimental mouse model.

Momtazi-Borojeni AA, Banach M, Sahebkar A. Momtazi-Borojeni AA, et al. Among authors: sahebkar a. Cardiol J. 2025;32(1):73-82. doi: 10.5603/cj.100585. Epub 2025 Jan 8. Cardiol J. 2025. PMID: 39776050 Free PMC article.

98

Drug repositioning for Parkinson's disease: An emphasis on artificial intelligence approaches.

Karimi-Sani I, Sharifi M, Abolpour N, Lotfi M, Atapour A, Takhshid MA, Sahebkar A. Karimi-Sani I, et al. Among authors: sahebkar a. Ageing Res Rev. 2025 Feb;104:102651. doi: 10.1016/j.arr.2024.102651. Epub 2025 Jan 2. Ageing Res Rev. 2025. PMID: 39755176 Review.

99

The efficacy of curcumin-piperine supplementation in patients with nonproliferative diabetic retinopathy: An optical coherence tomography angiography-based randomized controlled trial.

Amini S, Dehghani A, Sahebkar A, Iraj B, Rezaeian-Ramsheh A, Askari G, Majeed M, Bagherniya M. Amini S, et al. Among authors: sahebkar a. J Res Med Sci. 2024 Oct 24;29:64. doi: 10.4103/jrms.jrms_174_24. eCollection 2024. J Res Med Sci. 2024. PMID: 39744187 Free PMC article.

100

Curcumin-based nanofibers: A promising approach for cancer therapy.

Rahiman N, Kesharwani P, Karav S, Sahebkar A. Rahiman N, et al. Among authors: sahebkar a. Pathol Res Pract. 2025 Feb;266:155791. doi: 10.1016/j.prp.2024.155791. Epub 2024 Dec 24. Pathol Res Pract. 2025. PMID: 39742832 Review.

101

Effect of statins on arterial wall inflammation as assessed by 18F-FDG PET CT: an updated systematic review and meta-analysis.

Jamialahmadi T, Reiner Ž, Simental-Mendia LE, Almahmeed W, Karav S, Eid AH, Giammarile F, Sahebkar A. Jamialahmadi T, et al. Among authors: sahebkar a. J Inflamm (Lond). 2024 Dec 18;21(1):52. doi: 10.1186/s12950-024-00421-x. J Inflamm (Lond). 2024. PMID: 39696570 Free PMC article.

102

Regulatory effects of statins on CCL2/CCR2 axis in cardiovascular diseases: new insight into pleiotropic effects of statins.

Gholamalizadeh H, Ensan B, Karav S, Jamialahmadi T, Sahebkar A. Gholamalizadeh H, et al. Among authors: sahebkar a. J Inflamm (Lond). 2024 Dec 18;21(1):51. doi: 10.1186/s12950-024-00420-y. J Inflamm (Lond). 2024. PMID: 39696507 Free PMC article.

103

Effects of trehalose on bone healing, physical function, and pain in patients with pertrochanteric fractures: a randomized controlled trial protocol.

Zandi R, Razani HO, Mehrvar A, Jowshan MR, Sahebkar A, Nikooyeh B, Zahedi H, Talebi S. Zandi R, et al. Among authors: sahebkar a. Trials. 2024 Dec 18;25(1):823. doi: 10.1186/s13063-024-08667-9. Trials. 2024. PMID: 39695828 Free PMC article.

104

Compromising the immunogenicity of diphtheria toxin-based immunotoxins through epitope engineering: An in silico approach.

Golichenari B, Heiat M, Rezaei E, Ramshini A, Sahebkar A, Gholipour N. Golichenari B, et al. Among authors: sahebkar a. J Pharmacol Toxicol Methods. 2025 Feb;131:107571. doi: 10.1016/j.vascn.2024.107571. Epub 2024 Dec 17. J Pharmacol Toxicol Methods. 2025. PMID: 39693813

105

PCSK7 levels in women with and without PCOS.

Atkin SL, Butler AE, Jamialahmadi T, Sahebkar A. Atkin SL, et al. Among authors: sahebkar a. J Clin Transl Endocrinol. 2024 Nov 28;38:100376. doi: 10.1016/j.jcte.2024.100376. eCollection 2024 Dec. J Clin Transl Endocrinol. 2024. PMID: 39691660 Free PMC article. No abstract available.

106

The correlation between indirect calorimetry data and the metabolic syndrome development in men and women.

Roudi F, Darroudi S, Saghi E, Hosseini SR, Kohantorabi M, Rezvani A, Jamialahmadi T, Sahebkar A, Moohebati M, Ghayour-Mobarhan M. Roudi F, et al. Among authors: sahebkar a. J Diabetes Metab Disord. 2024 Dec 14;24(1):1. doi: 10.1007/s40200-024-01521-4. eCollection 2025 Jun. J Diabetes Metab Disord. 2024. PMID: 39686919

107

Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities.

Askarizadeh F, Karav S, Jamialahmadi T, Sahebkar A. Askarizadeh F, et al. Among authors: sahebkar a. Pharmacol Rep. 2025 Feb;77(1):43-71. doi: 10.1007/s43440-024-00678-2. Epub 2024 Dec 16. Pharmacol Rep. 2025. PMID: 39680334 Review.

108

Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Global Nutrition Target Collaborators. Global Nutrition Target Collaborators. Lancet. 2025 Dec 21;404(10471):2543-2583. doi: 10.1016/S0140-6736(24)01821-X. Epub 2024 Dec 9. Lancet. 2025. PMID: 39667386 Free PMC article.

109

Beyond fat: Does semaglutide affect lean mass?

Jamialahmadi T, Eid AH, Gadde KM, Almahmeed W, Kroh M, Al Zein M, Sahebkar A. Jamialahmadi T, et al. Among authors: sahebkar a. Clin Nutr. 2025 Jan;44:104-108. doi: 10.1016/j.clnu.2024.12.004. Epub 2024 Dec 4. Clin Nutr. 2025. PMID: 39647240 Review.

110

Hepatic effects of GLP-1 mimetics in diabetic milieu: A mechanistic review of involved pathways.

Yaribeygi H, Kashian K, Moghaddam KI, Karim SR, Bagheri N, Karav S, Jamialahmadi T, Rizzo M, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. J Diabetes Complications. 2025 Jan;39(1):108928. doi: 10.1016/j.jdiacomp.2024.108928. Epub 2024 Dec 5. J Diabetes Complications. 2025. PMID: 39644538 Review.

111

Effect of oral trehalose supplementation on inflammation and wound healing in patients with peri-trochanteric fractures: study protocol for a randomised clinical trial.

Zandi R, Tavallaei Zavareh A, Mehrvar A, Jowshan MR, Sahebkar A, Nikooyeh B, Zahedi H, Talebi S. Zandi R, et al. Among authors: sahebkar a. BMJ Open. 2024 Dec 3;14(12):e092092. doi: 10.1136/bmjopen-2024-092092. BMJ Open. 2024. PMID: 39627130 Free PMC article.

112

Beyond digestion: Exploring how the gut microbiota modulates human social behaviors.

Abavisani M, Faraji N, Ebadpour N, Kesharwani P, Sahebkar A. Abavisani M, et al. Among authors: sahebkar a. Neuroscience. 2025 Jan 26;565:52-62. doi: 10.1016/j.neuroscience.2024.11.068. Epub 2024 Nov 29. Neuroscience. 2025. PMID: 39615647

113

Modulation of the ubiquitin-proteasome system by curcumin: Therapeutic implications in cancer.

Torghabe SY, Alavi P, Rostami S, Davies NM, Kesharwani P, Karav S, Sahebkar A. Torghabe SY, et al. Among authors: sahebkar a. Pathol Res Pract. 2025 Jan;265:155741. doi: 10.1016/j.prp.2024.155741. Epub 2024 Nov 26. Pathol Res Pract. 2025. PMID: 39612810 Review.

114

Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.

GBD 2021 HIV Collaborators. GBD 2021 HIV Collaborators. Lancet HIV. 2024 Dec;11(12):e807-e822. doi: 10.1016/S2352-3018(24)00212-1. Epub 2024 Nov 25. Lancet HIV. 2024. PMID: 39608393 Free PMC article.

115

The potential protective effects and mechanisms of fasting on neurodegenerative disorders: A narrative review.

Golpour-Hamedani S, Askari G, Khorvash F, Kesharwani P, Bagherniya M, Sahebkar A. Golpour-Hamedani S, et al. Among authors: sahebkar a. Brain Res. 2025 Feb 15;1849:149348. doi: 10.1016/j.brainres.2024.149348. Epub 2024 Nov 23. Brain Res. 2025. PMID: 39581525 Review.

116

Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy.

Rastegar-Pouyani N, Abdolvahab MH, Farzin MA, Zare H, Kesharwani P, Sahebkar A. Rastegar-Pouyani N, et al. Among authors: sahebkar a. Tissue Cell. 2024 Dec;91:102624. doi: 10.1016/j.tice.2024.102624. Epub 2024 Nov 19. Tissue Cell. 2024. PMID: 39581071 Review.

117

National and subnational burden of mental disorders in Iran (1990-2019): findings of the Global Burden of Disease 2019 study.

Iran Subnational Mental Health GBD Collaborators. Iran Subnational Mental Health GBD Collaborators. Lancet Glob Health. 2024 Dec;12(12):e1984-e1992. doi: 10.1016/S2214-109X(24)00342-5. Lancet Glob Health. 2024. PMID: 39577972 Free PMC article.

118

Exploring the antioxidant properties of semaglutide: A comprehensive review.

Yaribeygi H, Maleki M, Forouzanmehr B, Kesharwani P, Jamialahmadi T, Karav S, Sahebkar A. Yaribeygi H, et al. Among authors: sahebkar a. J Diabetes Complications. 2024 Dec;38(12):108906. doi: 10.1016/j.jdiacomp.2024.108906. Epub 2024 Nov 12. J Diabetes Complications. 2024. PMID: 39549371 Review.

119

Harnessing the power of targeted metal nanocarriers mediated photodynamic and photothermal therapy.

Chandra J, Nasir N, Wahab S, Sahebkar A, Kesharwani P. Chandra J, et al. Among authors: sahebkar a. Nanomedicine (Lond). 2024 Nov 15:1-19. doi: 10.1080/17435889.2024.2419820. Online ahead of print. Nanomedicine (Lond). 2024. PMID: 39545609 Review.

120

Lipid variability in drug-naïve individuals affected with Major Depressive Disorder: a systematic review and meta-analysis.

Ensan B, Hosseini ZS, Mirzaei M, Ghadiri Hakim H, Zafari N, Jamialahmdi T, Sahebkar A. Ensan B, et al. Among authors: sahebkar a. Int J Psychiatry Clin Pract. 2024 Jun;28(2):177-187. doi: 10.1080/13651501.2024.2427617. Epub 2024 Nov 15. Int J Psychiatry Clin Pract. 2024. PMID: 39545523

121

Utilizing ionic liquids as eco-friendly and sustainable carriers for delivering nucleic acids: A review on the revolutionary advancement in nano delivery systems.

Mirhadi E, Kesharwani P, Jha SK, Karav S, Sahebkar A. Mirhadi E, et al. Among authors: sahebkar a. Int J Biol Macromol. 2024 Dec;283(Pt 2):137582. doi: 10.1016/j.ijbiomac.2024.137582. Epub 2024 Nov 13. Int J Biol Macromol. 2024. PMID: 39542300 Review.

122

How does geographical diversity shape vaccine efficacy?

Abavisani M, Ansari B, Ebadpour N, Sahebkar A. Abavisani M, et al. Among authors: sahebkar a. Clin Exp Vaccine Res. 2024 Oct;13(4):271-300. doi: 10.7774/cevr.2024.13.4.271. Epub 2024 Oct 31. Clin Exp Vaccine Res. 2024. PMID: 39525670 Free PMC article. Review.

123

Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.

GBD 2021 Global Stillbirths Collaborators. GBD 2021 Global Stillbirths Collaborators. Lancet. 2024 Nov 16;404(10466):1955-1988. doi: 10.1016/S0140-6736(24)01925-1. Epub 2024 Nov 4. Lancet. 2024. PMID: 39510107 Free PMC article.

124

The Effect of Statin Therapy on Bone Metabolism Markers and Mineral Density: Aa GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.

Arabi SM, Chambari M, Bahrami LS, Jafari A, Bahari H, Reiner Ž, Sahebkar A. Arabi SM, et al. Among authors: sahebkar a. Adv Pharm Bull. 2024 Oct;14(3):591-603. doi: 10.34172/apb.2024.051. Epub 2024 Jun 22. Adv Pharm Bull. 2024. PMID: 39494267 Free PMC article. Review.

125

Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches.

Meybodi SM, Rabori VS, Salkhorde D, Jafari N, Zeinaly M, Mojodi E, Kesharwani P, Saberiyan M, Sahebkar A. Meybodi SM, et al. Among authors: sahebkar a. Cytokine. 2024 Dec;184:156794. doi: 10.1016/j.cyto.2024.156794. Epub 2024 Oct 29. Cytokine. 2024. PMID: 39489912 Review.

126

Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture.

Shakour N, Mahdinezhad MR, Asgharzadeh F, Khazaei M, Simental-Mendía LE, Roshan NM, Sahebkar A, Hadizadeh F. Shakour N, et al. Among authors: sahebkar a. J Diabetes Complications. 2024 Dec;38(12):108897. doi: 10.1016/j.jdiacomp.2024.108897. Epub 2024 Oct 22. J Diabetes Complications. 2024. PMID: 39489911

127

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Kesharwani P, Halwai K, Jha SK, Al Mughram MH, Almujri SS, Almalki WH, Sahebkar A. Kesharwani P, et al. Among authors: sahebkar a. Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z. Mol Cancer. 2024. PMID: 39482651 Free PMC article. Review.

128

Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing.

Abavisani M, Khoshrou A, Eshaghian S, Karav S, Sahebkar A. Abavisani M, et al. Among authors: sahebkar a. J Drug Target. 2025 Mar;33(3):341-367. doi: 10.1080/1061186X.2024.2424895. Epub 2024 Nov 12. J Drug Target. 2025. PMID: 39485073 Review.

129

Effect of Phytosterols on Serum Levels of C-Reactive Protein: A Time- and Dose-Response Meta-analysis of Randomized Controlled Trial.

Aslani S, Eslami MM, Fakourizad G, Faiz AF, Mohammadi K, Dehghan O, Imani D, Abbaspour A, Jamialahmadi T, Razi B, Sahebkar A. Aslani S, et al. Among authors: sahebkar a. High Blood Press Cardiovasc Prev. 2024 Nov;31(6):613-630. doi: 10.1007/s40292-024-00686-6. Epub 2024 Oct 30. High Blood Press Cardiovasc Prev. 2024. PMID: 39476284 Review.

130

Treatment with proton pump inhibitors is associated with secondary bacterial infections and sepsis in patients with COVID-19: a retrospective analysis of their joint impact on in-hospital prognosis.

Bianconi V, Mannarino MR, Figorilli F, Ricciutelli F, De Carlo S, Zullo V, Corba M, Sahebkar A, Greco A, Lombardini R, Paltriccia R, Pirro M. Bianconi V, et al. Among authors: sahebkar a. Ann Med. 2024 Dec;56(1):2399761. doi: 10.1080/07853890.2024.2399761. Epub 2024 Oct 30. Ann Med. 2024. PMID: 39475004 Free PMC article.

131

Effect of Statin Treatment on Lipoprotein-Associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.

Sahebkar A, Reiner Ž, Almahmeed W, Jamialahmadi T, Simental-Mendía LE. Sahebkar A, et al. Cardiovasc Drugs Ther. 2024 Oct 28. doi: 10.1007/s10557-024-07634-5. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 39466484 Review.

132

Decoy oligodeoxynucleotides: A promising therapeutic strategy for inflammatory skin disorders.

Mahjoubin-Tehran M, Rezaei S, Karav S, Kesharwani P, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: sahebkar a. Hum Immunol. 2024 Nov;85(6):111161. doi: 10.1016/j.humimm.2024.111161. Epub 2024 Oct 24. Hum Immunol. 2024. PMID: 39454315 Review.

133

Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019.

GBD 2019 Injuries Collaborators. GBD 2019 Injuries Collaborators. Public Health. 2024 Dec;237:212-231. doi: 10.1016/j.puhe.2024.06.011. Epub 2024 Oct 24. Public Health. 2024. PMID: 39454232

134

Beneficial effects of resveratrol on diabetes mellitus and its complications: focus on mechanisms of action.

Ahmadzadeh AM, Aliabadi MM, Mirheidari SB, Hamedi-Asil M, Garousi S, Mottahedi M, Sahebkar A. Ahmadzadeh AM, et al. Among authors: sahebkar a. Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2407-2442. doi: 10.1007/s00210-024-03527-4. Epub 2024 Oct 24. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39446148 Review.

135

Utilizing stimuli-responsive nanoparticles to deliver and enhance the anti-tumor effects of bilirubin.

Mirhadi E, Butler AE, Kesharwani P, Sahebkar A. Mirhadi E, et al. Among authors: sahebkar a. Biotechnol Adv. 2024 Dec;77:108469. doi: 10.1016/j.biotechadv.2024.108469. Epub 2024 Oct 18. Biotechnol Adv. 2024. PMID: 39427964 Review.

136

Effects of dietary curcumin on gene expression: An analysis of transcriptomic data in mice.

Mahjoubin-Tehran M, Hasan A, Eid AH, Almahmeed W, Kesharwani P, Butler AE, Jamialahmadi T, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Nov;263:155653. doi: 10.1016/j.prp.2024.155653. Epub 2024 Oct 11. Pathol Res Pract. 2024. PMID: 39426142 Review.

137

Recent update on anti-tumor mechanisms of valproic acid in glioblastoma multiforme.

Vatankhah A, Moghaddam SH, Afshari S, Afshari AR, Kesharwani P, Sahebkar A. Vatankhah A, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Nov;263:155636. doi: 10.1016/j.prp.2024.155636. Epub 2024 Oct 3. Pathol Res Pract. 2024. PMID: 39395298 Review.

138

The Wnt signaling cascade: a potential but untapped therapeutic target for monkeypox infection.

Faraji N, Abavisani M, Sahebkar A. Faraji N, et al. Among authors: sahebkar a. Drug Discov Today. 2024 Dec;29(12):104204. doi: 10.1016/j.drudis.2024.104204. Epub 2024 Oct 10. Drug Discov Today. 2024. PMID: 39393774 No abstract available.

139

Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay.

Mansour H, Slika H, Nasser SA, Pintus G, Khachab M, Sahebkar A, Eid AH. Mansour H, et al. Among authors: sahebkar a. Pharmacol Res. 2024 Nov;209:107452. doi: 10.1016/j.phrs.2024.107452. Epub 2024 Oct 8. Pharmacol Res. 2024. PMID: 39383791 Free article. Review.

140

Serum biochemical evaluation following administration of imidazolyl thiazolidinedione in streptozotocin-induced diabetic rats.

Shakour N, Mahdinezhad MR, Hadjzadeh MA, Sahebkar A, Hadizadeh F. Shakour N, et al. Among authors: sahebkar a. J Mol Histol. 2024 Dec;55(6):1315-1325. doi: 10.1007/s10735-024-10272-8. Epub 2024 Oct 9. J Mol Histol. 2024. PMID: 39382759

141

Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization.

Bemidinezhad A, Radmehr S, Moosaei N, Efati Z, Kesharwani P, Sahebkar A. Bemidinezhad A, et al. Among authors: sahebkar a. Nanomedicine (Lond). 2024;19(28):2391-2411. doi: 10.1080/17435889.2024.2403325. Epub 2024 Oct 9. Nanomedicine (Lond). 2024. PMID: 39382020 Review.

142

Epidemiology and outcomes of patients with tuberculosis requiring extracorporeal membrane oxygenation: An ELSO registry analysis.

Ait Hssain A, Vahedian-Azimi A, Schmidt M, Saif Ibrahim A, Ramanathan K, Fawzy Hassan I, Sahebkar A. Ait Hssain A, et al. Among authors: sahebkar a. Intensive Crit Care Nurs. 2025 Feb;86:103841. doi: 10.1016/j.iccn.2024.103841. Epub 2024 Oct 7. Intensive Crit Care Nurs. 2025. PMID: 39378527

143

Nutritional factors and physical frailty: Highlighting the role of functional nutrients in the prevention and treatment.

Ziaei R, Shahdadian F, Bagherniya M, Karav S, Sahebkar A. Ziaei R, et al. Among authors: sahebkar a. Ageing Res Rev. 2024 Nov;101:102532. doi: 10.1016/j.arr.2024.102532. Epub 2024 Oct 5. Ageing Res Rev. 2024. PMID: 39374829 Review.

144

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Tobacco Forecasting Collaborators. GBD 2021 Tobacco Forecasting Collaborators. Lancet Public Health. 2024 Oct;9(10):e729-e744. doi: 10.1016/S2468-2667(24)00166-X. Lancet Public Health. 2024. PMID: 39366729 Free PMC article.

145

Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials.

Karimi-Sani I, Molavi Z, Naderi S, Mirmajidi SH, Zare I, Naeimzadeh Y, Mansouri A, Tajbakhsh A, Savardashtaki A, Sahebkar A. Karimi-Sani I, et al. Among authors: sahebkar a. J Nanobiotechnology. 2024 Oct 4;22(1):601. doi: 10.1186/s12951-024-02882-x. J Nanobiotechnology. 2024. PMID: 39367418 Free PMC article. Review.

146

Environmental pollutants and alpha-synuclein toxicity in Parkinson's disease.

Roy S, Kakoty V, Sahebkar A, Md S, Kesharwani P. Roy S, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Nov;263:155605. doi: 10.1016/j.prp.2024.155605. Epub 2024 Sep 24. Pathol Res Pract. 2024. PMID: 39353322 Review.

147

Alkaloids in Cancer therapy: Targeting the tumor microenvironment and metastasis signaling pathways.

Koochaki R, Amini E, Zarehossini S, Zareh D, Haftcheshmeh SM, Jha SK, Kesharwani P, Shakeri A, Sahebkar A. Koochaki R, et al. Among authors: sahebkar a. Fitoterapia. 2024 Dec;179:106222. doi: 10.1016/j.fitote.2024.106222. Epub 2024 Sep 27. Fitoterapia. 2024. PMID: 39343104 Review.

148

Beyond the spice: The multifaceted role of curcumin in multiple sclerosis management.

Sahebkar A, Salehabadi S, Jamialahmadi T. Sahebkar A, et al. Complement Ther Med. 2024 Nov;86:103091. doi: 10.1016/j.ctim.2024.103091. Epub 2024 Sep 25. Complement Ther Med. 2024. PMID: 39332595 Free article. No abstract available.

149

Phenotypic and genotypic identification of class C and D β-lactamases in clinical isolates of Pseudomonas aeruginosa: a cross-sectional study.

Mohammadnezhad N, Nazari M, Mostafavi SKS, Sahebkar A, Khademi F. Mohammadnezhad N, et al. Among authors: sahebkar a. Health Sci Rep. 2024 Sep 24;7(9):e70095. doi: 10.1002/hsr2.70095. eCollection 2024 Sep. Health Sci Rep. 2024. PMID: 39323460 Free PMC article.

150

Di (2-ethyl hexyl) phthalate and its metabolite-induced metabolic syndrome: a review of molecular mechanisms.

Ashaari S, Jamialahmadi T, Davies NM, Almahmeed W, Sahebkar A. Ashaari S, et al. Among authors: sahebkar a. Drug Chem Toxicol. 2025 Mar;48(2):325-343. doi: 10.1080/01480545.2024.2405830. Epub 2024 Sep 25. Drug Chem Toxicol. 2025. PMID: 39322993 Review.

151

Unveiling the theranostic potential of SPIONs in Alzheimer's disease management.

Aminyavari S, Afshari AR, Ahmadi SS, Kesharwani P, Sanati M, Sahebkar A. Aminyavari S, et al. Among authors: sahebkar a. J Psychiatr Res. 2024 Nov;179:244-256. doi: 10.1016/j.jpsychires.2024.09.022. Epub 2024 Sep 20. J Psychiatr Res. 2024. PMID: 39321523 Review.

152

Statin Therapy and C-reactive Protein in Patients with Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Razi B, Imani D, Aslani S, Reiner Z, Sahebkar A. Razi B, et al. Among authors: sahebkar a. Curr Drug Targets. 2025;26(2):132-145. doi: 10.2174/0113894501302428240909150925. Curr Drug Targets. 2025. PMID: 39318006

153

Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Stroke Risk Factor Collaborators. GBD 2021 Stroke Risk Factor Collaborators. Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7. Lancet Neurol. 2024. PMID: 39304265 Free article.

154

Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.

GBD 2021 Antimicrobial Resistance Collaborators. GBD 2021 Antimicrobial Resistance Collaborators. Lancet. 2024 Sep 28;404(10459):1199-1226. doi: 10.1016/S0140-6736(24)01867-1. Epub 2024 Sep 16. Lancet. 2024. PMID: 39299261 Free PMC article.

155

Transforming hypercholesterolemia management: Spotlight on PCSK9 peptide vaccines.

Sahebkar A, Banach M. Sahebkar A, et al. Cell Rep Med. 2024 Sep 17;5(9):101726. doi: 10.1016/j.xcrm.2024.101726. Cell Rep Med. 2024. PMID: 39293395 Free PMC article.

156

The effectiveness of phytosomal curcumin on clinical and laboratory parameters of patients with multiple trauma admitted to the intensive care unit: a double-blind randomized placebo-controlled trial.

Mirjalili M, Sahebkar A, Hassanizadeh S, Kiani Z, Soleimani D, Amini S, Alikiaii B, Moallem SA, Askari G, Abbasi S, Bagherniya M. Mirjalili M, et al. Among authors: sahebkar a. BMC Complement Med Ther. 2024 Sep 17;24(1):335. doi: 10.1186/s12906-024-04639-3. BMC Complement Med Ther. 2024. PMID: 39289667 Free PMC article. Clinical Trial.

157

Curcuminoids as natural modulators of necroptosis: therapeutic implications.

Foroutan Z, Cicero AFG, Jamialahmadi T, Sahebkar A. Foroutan Z, et al. Among authors: sahebkar a. Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1299-1304. doi: 10.1007/s00210-024-03455-3. Epub 2024 Sep 17. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39287673 Review.

158

Engineering carbon-based nanomaterials for the delivery of platinum compounds: An innovative cancer disarming frontier.

Rahchamandi SYR, Mirhadi E, Gheybi F, Kazemi-Beydokhti A, Jaafari MR, Mostafavi E, Kesharwani P, Sahebkar A, Alavizadeh SH. Rahchamandi SYR, et al. Among authors: sahebkar a. Environ Res. 2024 Dec 1;262(Pt 2):119933. doi: 10.1016/j.envres.2024.119933. Epub 2024 Sep 13. Environ Res. 2024. PMID: 39278586 Review.

159

Molecular targets in SARS-CoV-2 infection: An update on repurposed drug candidates.

Rahmani D, Jafari A, Kesharwani P, Sahebkar A. Rahmani D, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Nov;263:155589. doi: 10.1016/j.prp.2024.155589. Epub 2024 Sep 8. Pathol Res Pract. 2024. PMID: 39276508 Review.

160

Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.

GBD 2021 Upper Respiratory Infections Otitis Media Collaborators. GBD 2021 Upper Respiratory Infections Otitis Media Collaborators. Lancet Infect Dis. 2025 Jan;25(1):36-51. doi: 10.1016/S1473-3099(24)00430-4. Epub 2024 Sep 9. Lancet Infect Dis. 2025. PMID: 39265593 Free PMC article.

161

Probiotics for autism spectrum disorder: An updated systematic review and meta-analysis of effects on symptoms.

Soleimanpour S, Abavisani M, Khoshrou A, Sahebkar A. Soleimanpour S, et al. Among authors: sahebkar a. J Psychiatr Res. 2024 Nov;179:92-104. doi: 10.1016/j.jpsychires.2024.09.009. Epub 2024 Sep 11. J Psychiatr Res. 2024. PMID: 39265200 Review.

162

Small molecules targeting mitochondria as an innovative approach to cancer therapy.

Kamble OS, Chatterjee R, Abishek KG, Chandra J, Alsayari A, Wahab S, Sahebkar A, Kesharwani P, Dandela R. Kamble OS, et al. Among authors: sahebkar a. Cell Signal. 2024 Dec;124:111396. doi: 10.1016/j.cellsig.2024.111396. Epub 2024 Sep 7. Cell Signal. 2024. PMID: 39251050 Review.

163

COVID-19 diagnosis on the basis of nanobiosensors' prompt interactivity: A holistic review.

Mohammadi M, Asvar Z, Solhjoo SP, Sarikhanikhorrami M, Abadi HG, Ghazizadeh S, Mahmoodi H, Habibolah NK, Moradi O, Kesharwani P, Amani AM, Sahebkar A. Mohammadi M, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Oct;262:155565. doi: 10.1016/j.prp.2024.155565. Epub 2024 Aug 29. Pathol Res Pract. 2024. PMID: 39226801 Review.

164

The Effect of Bariatric Surgery on PAI-1 Levels: A Systematic Review and Meta-analysis.

Jamialahamdi T, Mirhadi E, Almahmeed W, Sukhorukov VN, Eid AH, Salehabadi S, Sahebkar A. Jamialahamdi T, et al. Among authors: sahebkar a. Obes Surg. 2024 Oct;34(10):3876-3887. doi: 10.1007/s11695-024-07473-1. Epub 2024 Sep 2. Obes Surg. 2024. PMID: 39222193 Review.

165

Mycobacterium tuberculosis Detection Using CRISPR Technology: An Updated Systematic Review and Meta-analysis.

Abavisani M, Karbas Foroushan S, Khayami R, Sahebkar A. Abavisani M, et al. Among authors: sahebkar a. Mol Diagn Ther. 2024 Nov;28(6):777-790. doi: 10.1007/s40291-024-00741-x. Epub 2024 Aug 30. Mol Diagn Ther. 2024. PMID: 39212838 Review.

166

The differential expression of adipose tissue genes in short, medium and long-term periods after bariatric surgery.

Mahjoubin-Tehran M, Atkin SL, Jamialahmadi T, Kroh M, Eid AH, Almahmeed W, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: sahebkar a. Sci Rep. 2024 Aug 28;14(1):19991. doi: 10.1038/s41598-024-70629-7. Sci Rep. 2024. PMID: 39198660 Free PMC article.

167

Lipidomic profiling in patients with familial hypercholesterolemia: Abnormalities in glycerolipids and oxysterols.

Ganjali S, Cardenia V, Bonciolini A, Santos RD, Al-Rasadi K, Sahebkar A. Ganjali S, et al. Among authors: sahebkar a. Clin Biochem. 2024 Oct;131-132:110812. doi: 10.1016/j.clinbiochem.2024.110812. Epub 2024 Aug 27. Clin Biochem. 2024. PMID: 39197573

168

Harnessing the therapeutic potential of phytochemicals in neuroblastoma.

Ahmadi SS, Bagherzadeh O, Sargazi M, Kalantar F, Najafi MAE, Vahedi MM, Afshari AR, Sahebkar A. Ahmadi SS, et al. Among authors: sahebkar a. Biofactors. 2025 Jan-Feb;51(1):e2115. doi: 10.1002/biof.2115. Epub 2024 Aug 27. Biofactors. 2025. PMID: 39189819 Review.

169

Phenotypic switch of vascular smooth muscle cells in COVID-19: Role of cholesterol, calcium, and phosphate.

Ghanem L, Essayli D, Kotaich J, Zein MA, Sahebkar A, Eid AH. Ghanem L, et al. Among authors: sahebkar a. J Cell Physiol. 2024 Dec;239(12):e31424. doi: 10.1002/jcp.31424. Epub 2024 Aug 26. J Cell Physiol. 2024. PMID: 39188012 Free PMC article. Review.

170

The analgesic effect of curcumin and nano-curcumin in clinical and preclinical studies: a systematic review and meta-analysis.

Hajimirzaei P, Eyni H, Razmgir M, Abolfazli S, Pirzadeh S, Ahmadi Tabatabaei FS, Vasigh A, Yazdanian N, Ramezani F, Janzadeh A, Butler AE, Sahebkar A. Hajimirzaei P, et al. Among authors: sahebkar a. Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):393-416. doi: 10.1007/s00210-024-03369-0. Epub 2024 Aug 26. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39186190 Review.

171

The beneficial impact of curcumin on cardiac lipotoxicity.

Abolfazli S, Butler AE, Kesharwani P, Sahebkar A. Abolfazli S, et al. Among authors: sahebkar a. J Pharm Pharmacol. 2024 Oct 3;76(10):1269-1283. doi: 10.1093/jpp/rgae102. J Pharm Pharmacol. 2024. PMID: 39180454 Review.

172

Therapeutic potential of curcumin in autophagy modulation: Insights into the role of transcription factor EB.

Radbakhsh S, Kesharwani P, Sahebkar A. Radbakhsh S, et al. Among authors: sahebkar a. Mutat Res. 2024 Jul-Dec;829:111879. doi: 10.1016/j.mrfmmm.2024.111879. Epub 2024 Aug 12. Mutat Res. 2024. PMID: 39178722 Review.

173

FAP-Targeted Nanoparticle-based Imaging in Cancer: A Systematic Review.

Abbasi S, Khademi S, Montazerabadi A, Sahebkar A. Abbasi S, et al. Among authors: sahebkar a. J Biomed Phys Eng. 2024 Aug 1;14(4):323-334. doi: 10.31661/jbpe.v0i0.2404-1754. eCollection 2024 Aug. J Biomed Phys Eng. 2024. PMID: 39175559 Free PMC article. Review.

174

Bioinformatic analysis of the molecular targets of curcumin in colorectal cancer.

Mahmoudi A, Jamialahmadi T, Kesharwani P, Sahebkar A. Mahmoudi A, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Oct;262:155533. doi: 10.1016/j.prp.2024.155533. Epub 2024 Aug 11. Pathol Res Pract. 2024. PMID: 39173464

175

GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences.

Forouzanmehr B, Hemmati MA, Atkin SL, Jamialahmadi T, Yaribeygi H, Sahebkar A. Forouzanmehr B, et al. Among authors: sahebkar a. Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):351-362. doi: 10.1007/s00210-024-03384-1. Epub 2024 Aug 22. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39172148 Review.

176

The effect of curcumin-piperine supplementation on lipid profile, glycemic index, inflammation, and blood pressure in patients with type 2 diabetes mellitus and hypertriglyceridemia.

Hosseini H, Bagherniya M, Sahebkar A, Iraj B, Majeed M, Askari G. Hosseini H, et al. Among authors: sahebkar a. Phytother Res. 2024 Nov;38(11):5150-5161. doi: 10.1002/ptr.8304. Epub 2024 Aug 20. Phytother Res. 2024. PMID: 39165011 Clinical Trial.

177

Protective effect of curcumin against microplastic and nanoplastics toxicity.

Mashayekhi-Sardoo H, Sepahi S, Ghorani-Azam A, Askarpour H, Johnston TP, Sahebkar A. Mashayekhi-Sardoo H, et al. Among authors: sahebkar a. Int J Environ Health Res. 2025 May;35(5):1314-1353. doi: 10.1080/09603123.2024.2391465. Epub 2024 Aug 19. Int J Environ Health Res. 2025. PMID: 39161080 Review.

178

Survival rate and its predictors in HIV patients: A 15-year follow-up of 3030 patients.

Naghibifar Z, Janbakhsh A, Sajadipour M, Emadzadeh M, Naghipour A, Sahebkar A. Naghibifar Z, et al. Among authors: sahebkar a. J Infect Public Health. 2024 Sep;17(9):102520. doi: 10.1016/j.jiph.2024.102520. Epub 2024 Aug 12. J Infect Public Health. 2024. PMID: 39146697 Free article.

179

Protective effects of curcumin against spinal cord injury.

Razavi SM, Khayatan D, Najafi Arab Z, Hosseini Y, Khanahmadi M, Momtaz S, Jamialahmadi T, Johnston TP, Abdolghaffari AH, Sahebkar A. Razavi SM, et al. Among authors: sahebkar a. JOR Spine. 2024 Aug 14;7(3):e1364. doi: 10.1002/jsp2.1364. eCollection 2024 Sep. JOR Spine. 2024. PMID: 39144499 Free PMC article. Review.

180

Advancements in biosensor technologies for fibrinogen detection in cardiovascular disorders.

Ranjbari S, Almahmeed W, Kesharwani P, Sahebkar A. Ranjbari S, et al. Among authors: sahebkar a. Talanta. 2024 Dec 1;280:126687. doi: 10.1016/j.talanta.2024.126687. Epub 2024 Aug 9. Talanta. 2024. PMID: 39126966 Review.

181

Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits.

Forouzanmehr B, Hedayati AH, Gholami E, Hemmati MA, Maleki M, Butler AE, Jamialahmadi T, Kesharwani P, Yaribeygi H, Sahebkar A. Forouzanmehr B, et al. Among authors: sahebkar a. Cell Signal. 2024 Oct;122:111335. doi: 10.1016/j.cellsig.2024.111335. Epub 2024 Aug 6. Cell Signal. 2024. PMID: 39117253 Review.

182

Advancements in curcumin-loaded PLGA nanoparticle delivery systems: progressive strategies in cancer therapy.

Keshavarz Shahbaz S, Koushki K, Izadi O, Penson PE, Sukhorukov VN, Kesharwani P, Sahebkar A. Keshavarz Shahbaz S, et al. Among authors: sahebkar a. J Drug Target. 2024 Dec;32(10):1207-1232. doi: 10.1080/1061186X.2024.2389892. Epub 2024 Aug 12. J Drug Target. 2024. PMID: 39106154 Review.

183

Auraptene inhibits migration, invasion and metastatic behavior of human malignant glioblastoma cells: An in vitro and in silico study.

Mousavi SH, Jalili-Nik M, Soukhtanloo M, Soltani A, Abbasinezhad-Moud F, Mollazadeh H, Shakeri F, Bibak B, Sahebkar A, Afshari AR. Mousavi SH, et al. Among authors: sahebkar a. Avicenna J Phytomed. 2024 May-Jun;14(3):349-364. doi: 10.22038/AJP.2023.23586. Avicenna J Phytomed. 2024. PMID: 39086858 Free PMC article.

184

Targeting the Akt signaling pathway: Exploiting curcumin's anticancer potential.

Aliyari M, Hashemy SI, Hashemi SF, Reihani A, Kesharwani P, Hosseini H, Sahebkar A. Aliyari M, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Sep;261:155479. doi: 10.1016/j.prp.2024.155479. Epub 2024 Jul 20. Pathol Res Pract. 2024. PMID: 39068859 Review.

185

Differential expression of long non-coding RNAs in colon cancer: Insights from transcriptomic analysis.

Ahmadirad H, Pourghadamyari H, Hadizadeh M, Ali-Kheyl M, Eslami O, Afgar A, Sayadi AR, Mahmoodi M, Kesharwani P, Sahebkar A. Ahmadirad H, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Sep;261:155477. doi: 10.1016/j.prp.2024.155477. Epub 2024 Jul 17. Pathol Res Pract. 2024. PMID: 39067175

186

The clinical prognostic significance of miR-140-5p expression in patients with cancer: A Meta and Bioinformatic analysis.

Pashirzad M, Kesharwani P, Sahebkar A. Pashirzad M, et al. Among authors: sahebkar a. Pathol Res Pract. 2024 Sep;261:155475. doi: 10.1016/j.prp.2024.155475. Epub 2024 Jul 25. Pathol Res Pract. 2024. PMID: 39067174

187

Efficacy of statin therapy in reducing epicardial adipose tissue: a systematic review and meta-analysis.

Jamialahmadi T, Simental-Mendia LE, Eid AH, Almahmeed W, Salehabadi S, Al-Rasadi K, Banach M, Sahebkar A. Jamialahmadi T, et al. Among authors: sahebkar a. Arch Med Sci. 2024 Jun 3;20(3):997-1001. doi: 10.5114/aoms/189575. eCollection 2024. Arch Med Sci. 2024. PMID: 39050169 Free PMC article.

188

Stimuli-responsive nanotheranostic systems conjugated with AIEgens for advanced cancer bio-imaging and treatment.

Oroojalian F, Azizollahi F, Kesharwani P, Sahebkar A. Oroojalian F, et al. Among authors: sahebkar a. J Control Release. 2024 Sep;373:766-802. doi: 10.1016/j.jconrel.2024.07.048. Epub 2024 Aug 2. J Control Release. 2024. PMID: 39047871 Review.

189

Leptin is a potential biomarker of childhood obesity and an indicator of the effectiveness of weight-loss interventions.

Al Zein M, Akomolafe AF, Mahmood FR, Khrayzat A, Sahebkar A, Pintus G, Kobeissy F, Eid AH. Al Zein M, et al. Among authors: sahebkar a. Obes Rev. 2024 Nov;25(11):e13807. doi: 10.1111/obr.13807. Epub 2024 Jul 23. Obes Rev. 2024. PMID: 39044542 Review.

190

The Association between Serum Follistatin-like Proteins and Cardiovascular Diseases: A Systematic Review and Meta-analysis.

Ahmadzadeh AM, Khodashahi R, Shabestari MM, Aliakbarian M, Sahebkar A, Arjmand MH. Ahmadzadeh AM, et al. Among authors: sahebkar a. Curr Cardiol Rev. 2024;20(6):e180724231994. doi: 10.2174/011573403X304195240715103930. Curr Cardiol Rev. 2024. PMID: 39034719 Free PMC article.

191

Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases.

Keshavarz Shahbaz S, Koushki K, Keshavarz Hedayati S, McCloskey AP, Kesharwani P, Naderi Y, Sahebkar A. Keshavarz Shahbaz S, et al. Among authors: sahebkar a. Med Res Rev. 2024 Nov;44(6):2793-2824. doi: 10.1002/med.22064. Epub 2024 Jul 19. Med Res Rev. 2024. PMID: 39031446 Review.

192

Effect of extracorporeal shockwave therapy on plantar fascia thickness in plantar fasciitis: a systematic review and meta-analysis of randomized controlled trials.

Simental-Mendía M, Simental-Mendía LE, Sánchez-García A, Sahebkar A, Jamialahmadi T, Vilchez-Cavazos F, Peña-Martínez VM, Acosta-Olivo C. Simental-Mendía M, et al. Among authors: sahebkar a. Arch Orthop Trauma Surg. 2024 Aug;144(8):3503-3516. doi: 10.1007/s00402-024-05464-6. Epub 2024 Jul 18. Arch Orthop Trauma Surg. 2024. PMID: 39023569 Review.

193

Effect of trehalose on mortality and disease severity in ICU-admitted patients: Protocol for a triple-blind, randomized, placebo-controlled clinical trial.

Sahranavard M, Hosseinjani H, Emadzadeh M, Jamialahmadi T, Sahebkar A. Sahranavard M, et al. Among authors: sahebkar a. Contemp Clin Trials Commun. 2024 Jun 18;40:101324. doi: 10.1016/j.conctc.2024.101324. eCollection 2024 Aug. Contemp Clin Trials Commun. 2024. PMID: 39021672 Free PMC article.

194

Publisher Correction: Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020.

Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Vision Loss Expert Group of the Global Burden of Disease Study, et al. Eye (Lond). 2024 Aug;38(11):2229-2231. doi: 10.1038/s41433-024-03161-7. Eye (Lond). 2024. PMID: 39014211 Free PMC article. No abstract available.

195

Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.

GBD 2021 Gout Collaborators. GBD 2021 Gout Collaborators. Lancet Rheumatol. 2024 Aug;6(8):e507-e517. doi: 10.1016/S2665-9913(24)00117-6. Epub 2024 Jul 9. Lancet Rheumatol. 2024. PMID: 38996590 Free PMC article.

196

Effect of Ozone Therapy on Diabetes-related Foot Ulcer Outcomes: A Systematic Review and Meta-analysis.

Izadi M, Jafari-Oori M, Eftekhari Z, Jafari NJ, Maybodi MK, Heydari S, Vahedian-Azimi A, Atkin SL, Jamialahmadi T, Sahebkar A. Izadi M, et al. Among authors: sahebkar a. Curr Pharm Des. 2024;30(27):2152-2166. doi: 10.2174/0113816128302890240521065453. Curr Pharm Des. 2024. PMID: 38982924

197

Prevalence and mechanisms of aminoglycoside resistance among drug-resistant Pseudomonas aeruginosa clinical isolates in Iran.

Saeli N, Jafari-Ramedani S, Ramazanzadeh R, Nazari M, Sahebkar A, Khademi F. Saeli N, et al. Among authors: sahebkar a. BMC Infect Dis. 2024 Jul 9;24(1):680. doi: 10.1186/s12879-024-09585-6. BMC Infect Dis. 2024. PMID: 38982386 Free PMC article.

198

The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trials.

Mozaffari S, Aliari M, Emamgholipour S, Hosseini H, Amirkiasar PR, Zare M, Katsiki N, Panahi G, Sahebkar A. Mozaffari S, et al. Among authors: sahebkar a. J Diabetes Complications. 2024 Aug;38(8):108780. doi: 10.1016/j.jdiacomp.2024.108780. Epub 2024 Jun 6. J Diabetes Complications. 2024. PMID: 38968867

199

Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020.

Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Vision Loss Expert Group of the Global Burden of Disease Study, et al. Eye (Lond). 2024 Aug;38(11):2083-2101. doi: 10.1038/s41433-024-03106-0. Epub 2024 Jul 4. Eye (Lond). 2024. PMID: 38965322 Free PMC article.

200

Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020.

Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Vision Loss Expert Group of the Global Burden of Disease Study, et al. Eye (Lond). 2024 Aug;38(11):2070-2082. doi: 10.1038/s41433-024-03050-z. Epub 2024 Jul 4. Eye (Lond). 2024. PMID: 38965321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,043 results

Search Page

Filters